Cue Health To Provide COVID-19 Testing For 2021-22 NBA Season
NEW YORK and SAN DIEGO, Oct. 14, 2021 /PRNewswire/ -- Cue Health Inc. (Nasdaq: HLTH), a mission-driven healthcare technology company, and the National Basketball Association (NBA) today announced that Cue will serve as the league's Official Home and Point of Care Test for the 2021-22 season. The Cue COVID-19 Test for Home and Over The Counter (OTC) Use is the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without physician supervision or a prescription.
Expanding on a relationship that began during the 2020 NBA Restart in Orlando, Cue will provide all 30 NBA teams and the league's referees with the integrated Cue platform, which features both the portable Cue Health Monitoring System and easy-to-use Cue COVID-19 tests for use during the 2021-22 NBA season.
Cue's platform is a molecular diagnostic system that delivers results directly to mobile smart devices – both Android and iOS – in about 20 minutes. The Cue Health Enterprise Dashboard allows for test results to be shared among players, teams, doctors, and the league through a secure, web-based application.
"The NBA has been at the forefront of health and safety from the beginning of the COVID-19 pandemic and we are proud to expand our relationship to become the league's Official Home and Point of Care Test," said Ayub Khattak, co-founder and CEO of Cue. "Since the NBA returned to the court last year, we have worked closely with them to make our fast and accurate testing available anywhere, anytime to prioritize players' health while enabling more effective decision-making throughout the league. For the coming season, we're honored to have the privilege of helping keep players, coaches, staff, referees, and their families healthy."
"After exploring a number of different at-home and point of care COVID-19 testing options for the upcoming season, we selected Cue thanks to its combination of accuracy, information management, ease of use, and speed," said David Weiss, NBA Senior Vice President, Player Matters. "The health and safety of our players, coaches, staff and referees continue to be at the forefront of all of our decision-making, and we're thrilled to be able to employ the Cue platform as a part of our Health & Safety Protocols for the 2021-22 season."
After collaborating during the 2020 NBA Restart in Orlando, the NBA began distributing the Cue Health Monitoring System and Cue COVID-19 tests to support regular testing of members of the NBA community at home and while traveling during the latter part of the 2020-21 season, following Cue Health's receipt of FDA Emergency Use Authorization (EUA) for Home and Over The Counter Use. Results of this home-testing program are expected to be published in a scientific journal later this year. Cue previously received EUA from the FDA in June of 2020 for its Cue COVID-19 Test for use in clinical and point of care settings.
About Cue Health
About the NBA
These products have not been FDA cleared or approved; but have been authorized by FDA under an EUA. These products have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of these products is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cue-health-to-provide-covid-19-testing-for-2021-22-nba-season-301400121.html
SOURCE Cue Health Inc.
Company Codes: NASDAQ-NMS:HLTH
© 2021 PR Newswire. All Rights Reserved.